Asia Pacific Drug Delivery Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End Users)
The Asia Pacific drug delivery market is expected to grow from US$ 4,42,973.70 million in 2023 to US$ 6,67,842.74 million by 2028. It is estimated to register a CAGR of 8.6% from 2023 to 2028.
Growing Demand for Noninvasive Drug Delivery Systems Fuel Asia Pacific Drug Delivery Market
Low patient compliance is a notable concern among physicians and medical device manufacturers. Hence, manufacturers are focusing on developing user-friendly and intuitive drug delivery systems that provide high patient comfort. Physicians, caregivers, and patients seek more patient-centric solutions, evaluating delivery systems and packaging options to encourage patients to take their medications as directed. Accurately measured doses and easy-to-use packaging with clear labeling are essential to meet self-sufficiency needs. The packaging must also be childproof, and it should prohibit counterfeiting.
Unit-dose packaging in innovative forms is increasingly used to improve patient compliance with prescribed drug therapy. A unit dose pack or container is filled precisely to contain medicines in quantities intended for a single dose. These features reduce medication errors because a drug's identity is quickly confirmed, and packaging ensures that patients take the correct dose of medicines. Drug manufacturers are now focusing on drug delivery systems that offer ease of use, portability, and convenience for patients taking drugs at locations other than home. Unither Pharmaceuticals—specializing in the development and contract manufacturing of sterile, single-dose pharmaceuticals—offers a range of convenient and easy-to-use dosage forms and delivery systems. Various forms include stick packs, single-dose vials with blow-fill-seal (BFS) technology, and effervescent tablets. Drug delivery systems that use BFS and stick-pack technologies help ensure accurate dosages and provide patients with a safer, portable, and more convenient way of adhering to their treatment regimen. These single-dose systems benefit manufacturers by aiding differentiation between different drug products and by extending product lifecycles.
Novo Nordisk has developed a FlexTouch insulin pen that requires less force to inject, an end-of-dose click to ensure accurate dose delivery, and a thin needle to reduce pain while injecting. Further, nasal sprays trickle down the throat, which is one of the main problems with nasal sprays; hence, OptiNose has developed an innovative inhaler that specifically delivers the medication in the nasal cavity. Companies also emphasize increasing convenience for patients by enabling them to use the same device they have become comfortable and familiar with to treat new indications. GlaxoSmithKline offers Breo Ellipta, an inhaler, for treating chronic obstructive pulmonary disease (COPD) and asthma patients, in addition to its initial indication as a once-a-day respiratory inhaler. A few companies are also developing devices that allow the transfer of more viscous drug products, larger molecules, and higher dose concentrations that are often difficult and painful to inject through manual delivery methods. Such innovative products help in improving patient compliance and reduce the chances of medication errors. Thus, the growing focus on patient compliance and satisfaction provides significant opportunities for the growth of the drug delivery systems market in Asia Pacific.
Asia Pacific Drug Delivery Market Overview
Asia Pacific is the fastest-growing market for drug delivery devices globally, with China, India, and Japan being the three major contributors. The Asia Pacific drug delivery market is driven by the increasing awareness of chronic disorders in the population and growing number of pharmaceutical and biotechnology companies focusing on their geographical expansion and other strategies in the countries in Asia Pacific. Additionally, the rise in research centers and government funding fuels the market growth. Also, increasing demand for therapeutics and growing medical tourism in Thailand, Singapore, and Malaysia are driving the market in this region.
Asia Pacific Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Drug Delivery Market Segmentation
The Asia Pacific drug delivery market is segmented into route of administration, distribution channel, end user, and country.
Based on route of administration, the Asia Pacific drug delivery market is segmented into injectable drug delivery, oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held a larger share of the Asia Pacific drug delivery market in 2023.
Based on distribution channel, the Asia Pacific drug delivery market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the Asia Pacific drug delivery market in 2023.
Based on end user, the Asia Pacific drug delivery market is segmented into hospitals and clinics, home care settings, and other end users. The hospitals and clinics segment held the largest share of the Asia Pacific drug delivery market in 2023.
Based on country, the Asia Pacific drug delivery market is segmented into Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific. Japan dominated the share of the Asia Pacific drug delivery market in 2023.
Bausch Health Companies Inc, Baxter International Inc, Becton Dickinson and Co, Boehringer Ingelheim International GmbH, Boston Scientific Corp, Gerresheimer AG, GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Novo Nordisk AS, and Pfizer Inc are the leading companies operating in the Asia Pacific drug delivery market.
Growing Demand for Noninvasive Drug Delivery Systems Fuel Asia Pacific Drug Delivery Market
Low patient compliance is a notable concern among physicians and medical device manufacturers. Hence, manufacturers are focusing on developing user-friendly and intuitive drug delivery systems that provide high patient comfort. Physicians, caregivers, and patients seek more patient-centric solutions, evaluating delivery systems and packaging options to encourage patients to take their medications as directed. Accurately measured doses and easy-to-use packaging with clear labeling are essential to meet self-sufficiency needs. The packaging must also be childproof, and it should prohibit counterfeiting.
Unit-dose packaging in innovative forms is increasingly used to improve patient compliance with prescribed drug therapy. A unit dose pack or container is filled precisely to contain medicines in quantities intended for a single dose. These features reduce medication errors because a drug's identity is quickly confirmed, and packaging ensures that patients take the correct dose of medicines. Drug manufacturers are now focusing on drug delivery systems that offer ease of use, portability, and convenience for patients taking drugs at locations other than home. Unither Pharmaceuticals—specializing in the development and contract manufacturing of sterile, single-dose pharmaceuticals—offers a range of convenient and easy-to-use dosage forms and delivery systems. Various forms include stick packs, single-dose vials with blow-fill-seal (BFS) technology, and effervescent tablets. Drug delivery systems that use BFS and stick-pack technologies help ensure accurate dosages and provide patients with a safer, portable, and more convenient way of adhering to their treatment regimen. These single-dose systems benefit manufacturers by aiding differentiation between different drug products and by extending product lifecycles.
Novo Nordisk has developed a FlexTouch insulin pen that requires less force to inject, an end-of-dose click to ensure accurate dose delivery, and a thin needle to reduce pain while injecting. Further, nasal sprays trickle down the throat, which is one of the main problems with nasal sprays; hence, OptiNose has developed an innovative inhaler that specifically delivers the medication in the nasal cavity. Companies also emphasize increasing convenience for patients by enabling them to use the same device they have become comfortable and familiar with to treat new indications. GlaxoSmithKline offers Breo Ellipta, an inhaler, for treating chronic obstructive pulmonary disease (COPD) and asthma patients, in addition to its initial indication as a once-a-day respiratory inhaler. A few companies are also developing devices that allow the transfer of more viscous drug products, larger molecules, and higher dose concentrations that are often difficult and painful to inject through manual delivery methods. Such innovative products help in improving patient compliance and reduce the chances of medication errors. Thus, the growing focus on patient compliance and satisfaction provides significant opportunities for the growth of the drug delivery systems market in Asia Pacific.
Asia Pacific Drug Delivery Market Overview
Asia Pacific is the fastest-growing market for drug delivery devices globally, with China, India, and Japan being the three major contributors. The Asia Pacific drug delivery market is driven by the increasing awareness of chronic disorders in the population and growing number of pharmaceutical and biotechnology companies focusing on their geographical expansion and other strategies in the countries in Asia Pacific. Additionally, the rise in research centers and government funding fuels the market growth. Also, increasing demand for therapeutics and growing medical tourism in Thailand, Singapore, and Malaysia are driving the market in this region.
Asia Pacific Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Drug Delivery Market Segmentation
The Asia Pacific drug delivery market is segmented into route of administration, distribution channel, end user, and country.
Based on route of administration, the Asia Pacific drug delivery market is segmented into injectable drug delivery, oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held a larger share of the Asia Pacific drug delivery market in 2023.
Based on distribution channel, the Asia Pacific drug delivery market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the Asia Pacific drug delivery market in 2023.
Based on end user, the Asia Pacific drug delivery market is segmented into hospitals and clinics, home care settings, and other end users. The hospitals and clinics segment held the largest share of the Asia Pacific drug delivery market in 2023.
Based on country, the Asia Pacific drug delivery market is segmented into Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific. Japan dominated the share of the Asia Pacific drug delivery market in 2023.
Bausch Health Companies Inc, Baxter International Inc, Becton Dickinson and Co, Boehringer Ingelheim International GmbH, Boston Scientific Corp, Gerresheimer AG, GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Novo Nordisk AS, and Pfizer Inc are the leading companies operating in the Asia Pacific drug delivery market.
1. INTRODUCTION
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Drug Delivery Market – by Route of Administration
1.3.2 Asia Pacific Drug Delivery Market – by Distribution Channel
1.3.3 Asia Pacific Drug Delivery Market – by End User
1.3.4 Asia Pacific Drug Delivery Market – by Country
2. ASIA PACIFIC DRUG DELIVERY MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ASIA PACIFIC DRUG DELIVERY MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Expert’s Opinion
5. ASIA PACIFIC DRUG DELIVERY MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rising Incidence of Chronic Diseases
5.1.2 Growing Demand for Noninvasive Drug Delivery Systems
5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
5.2 Key Market Restraints
5.2.1 High Cost Associated with Development of Drugs and Delivery Systems
5.2.2 Product Recalls in Drug Delivery Systems
5.3 Key Market Opportunities
5.3.1 Focus on Improving Patient Compliance
5.4 Future Trends
5.4.1 Strategic Developments and Product Launches
5.5 Impact analysis
6. DRUG DELIVERY MARKET – ASIA PACIFIC ANALYSIS
6.1 Asia Pacific Drug Delivery Market Revenue Forecast and Analysis
7. ASIA PACIFIC DRUG DELIVERY MARKET – REVENUE AND FORECAST TO 2028 – BY ROUTE OF ADMINISTRATION
7.1 Overview
7.2 Asia Pacific Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
7.3 Injectable Drug Delivery
7.3.1 Overview
7.3.2 Injectable Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Conventional Injection Devices
7.3.2.1.1 Overview
7.3.2.1.2 Conventional Injection Devices: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Advanced Devices
7.3.2.2.1 Overview
7.3.2.2.2 Advanced Devices: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Oral Drug Delivery
7.4.1 Overview
7.4.2 Oral Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Solid Oral Drugs
7.4.2.1.1 Overview
7.4.2.1.2 Solid Oral Drugs: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.2 Liquid Oral Drugs
7.4.2.2.1 Overview
7.4.2.2.2 Liquid Oral Drugs: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.3 Semi-solid Oral Drugs
7.4.2.3.1 Overview
7.4.2.3.2 Semi-solid Oral Drugs: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Topical Drug Delivery
7.5.1 Overview
7.5.2 Topical Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.1 Semi-solid Topical Drug Delivery
7.5.2.1.1 Overview
7.5.2.1.2 Semi-solid Topical Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.2 Liquid Topical Drug Delivery Formulations
7.5.2.2.1 Overview
7.5.2.2.2 Liquid Topical Drug Delivery Formulations: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.3 Solid Topical Drug Delivery Formulations
7.5.2.3.1 Overview
7.5.2.3.2 Solid Topical Drug Delivery Formulations: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.4 Transdermal
7.5.2.4.1 Overview
7.5.2.4.2 Transdermal Patches: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Transmucosal Drug Delivery
7.6.1 Overview
7.6.2 Transmucosal Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.1 Pulmonary and Nasal Drug Delivery
7.6.2.1.1 Overview
7.6.2.1.2 Pulmonary and Nasal Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.2 Buccal and Sublingual Drug Delivery
7.6.2.2.1 Overview
7.6.2.2.2 Buccal and Sublingual Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.3 Rectal Transmucosal Drug Delivery
7.6.2.3.1 Overview
7.6.2.3.2 Rectal Transmucosal Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.4 Vaginal Transmucosal Drug Delivery
7.6.2.4.1 Overview
7.6.2.4.2 Vaginal Transmucosal Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Implantable Drug Delivery
7.7.1 Overview
7.7.2 Implantable Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Ocular Drug Delivery
7.8.1 Overview
7.8.2 Ocular Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.1 Eye Drops and Sprays
7.8.2.1.1 Overview
7.8.2.1.2 Eye Drops and Sprays: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.2 Gels and Ointments
7.8.2.2.1 Overview
7.8.2.2.2 Gels and Ointments: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.3 Ocular Inserts and Punctal Plugs
7.8.2.3.1 Overview
7.8.2.3.2 Ocular Inserts and Punctal Plugs: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.4 Therapeutic Contact Lens
7.8.2.4.1 Overview
7.8.2.4.2 Therapeutic Contact Lens: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
8. ASIA PACIFIC DRUG DELIVERY MARKET – REVENUE AND FORECAST TO 2028 – BY DISTRIBUTION CHANNEL
8.1 Overview
8.2 Asia Pacific Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Retail Pharmacies
8.4.1 Overview
8.4.2 Retail Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Online Pharmacies
8.5.1 Overview
8.5.2 Online Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
9. ASIA PACIFIC DRUG DELIVERY MARKET – REVENUE AND FORECAST TO 2028 – BY END USER
9.1 Overview
9.2 Asia Pacific Drug Delivery Systems Market Revenue Share, by End User (2022and 2028)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Home Care Settings
9.4.1 Overview
9.4.2 Home Care Settings: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Other End User
9.5.1 Overview
9.5.2 Other End User: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
10. ASIA PACIFIC DRUG DELIVERY MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Overview
10.1.1 Asia Pacific Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
10.1.1.1 China: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 China: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 China: Asia Pacific Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.1.3.1 China: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.2 China: Asia Pacific Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.3 China: Asia Pacific Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.4 China: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.5 China: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.4 China: Asia Pacific Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.1.5 China: Asia Pacific Drug Delivery Market, by End User 2020-2028 (US$ Million)
10.1.1.2 Japan: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Japan: Asia Pacific Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.2.3.1 Japan: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.2 Japan: Asia Pacific Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.3 Japan: Asia Pacific Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.4 Japan: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.5 Japan: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.4 Japan: Asia Pacific Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.2.5 Japan: Asia Pacific Drug Delivery Market, by End User 2020-2028 (US$ Million)
10.1.1.3 India: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 India: Asia Pacific Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.3.3.1 India: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.2 India: Asia Pacific Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.3 India: Asia Pacific Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.4 India: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.5 India: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.4 India: Asia Pacific Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.3.5 India: Asia Pacific Drug Delivery Market, by End User 2020-2028 (US$ Million)
10.1.1.4 South Korea: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 South Korea: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 South Korea: Asia Pacific Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.4.3.1 South Korea: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.4.3.2 South Korea: Asia Pacific Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.4.3.3 South Korea: Asia Pacific Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.4.3.4 South Korea: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.4.3.5 South Korea: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.4.4 South Korea: Asia Pacific Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.4.5 South Korea: Asia Pacific Drug Delivery Market, by End User 2020-2028 (US$ Million)
10.1.1.5 Australia: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Australia: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Australia: Asia Pacific Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.5.3.1 Australia: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.5.3.2 Australia: Asia Pacific Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.5.3.3 Australia: Asia Pacific Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.5.3.4 Australia: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.5.3.5 Australia: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.5.4 Australia: Asia Pacific Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.5.5 Australia: Asia Pacific Drug Delivery Market, by End User 2020-2028 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.6.3.1 Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.6.3.2 Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.6.3.3 Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.6.3.4 Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.6.3.5 Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by End User 2020-2028 (US$ Million)
11. ASIA PACIFIC DRUG DELIVERY MARKET – INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in Asia Pacific Drug Delivery Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Becton Dickinson and Co
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Novo Nordisk AS
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Baxter International Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Gerresheimer AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 GlaxoSmithKline Plc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bausch Health Companies Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Boehringer Ingelheim International GmbH
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Novartis AG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.11 Johnson & Johnson
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Pfizer Inc
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Drug Delivery Market – by Route of Administration
1.3.2 Asia Pacific Drug Delivery Market – by Distribution Channel
1.3.3 Asia Pacific Drug Delivery Market – by End User
1.3.4 Asia Pacific Drug Delivery Market – by Country
2. ASIA PACIFIC DRUG DELIVERY MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ASIA PACIFIC DRUG DELIVERY MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Expert’s Opinion
5. ASIA PACIFIC DRUG DELIVERY MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rising Incidence of Chronic Diseases
5.1.2 Growing Demand for Noninvasive Drug Delivery Systems
5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
5.2 Key Market Restraints
5.2.1 High Cost Associated with Development of Drugs and Delivery Systems
5.2.2 Product Recalls in Drug Delivery Systems
5.3 Key Market Opportunities
5.3.1 Focus on Improving Patient Compliance
5.4 Future Trends
5.4.1 Strategic Developments and Product Launches
5.5 Impact analysis
6. DRUG DELIVERY MARKET – ASIA PACIFIC ANALYSIS
6.1 Asia Pacific Drug Delivery Market Revenue Forecast and Analysis
7. ASIA PACIFIC DRUG DELIVERY MARKET – REVENUE AND FORECAST TO 2028 – BY ROUTE OF ADMINISTRATION
7.1 Overview
7.2 Asia Pacific Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
7.3 Injectable Drug Delivery
7.3.1 Overview
7.3.2 Injectable Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Conventional Injection Devices
7.3.2.1.1 Overview
7.3.2.1.2 Conventional Injection Devices: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Advanced Devices
7.3.2.2.1 Overview
7.3.2.2.2 Advanced Devices: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Oral Drug Delivery
7.4.1 Overview
7.4.2 Oral Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Solid Oral Drugs
7.4.2.1.1 Overview
7.4.2.1.2 Solid Oral Drugs: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.2 Liquid Oral Drugs
7.4.2.2.1 Overview
7.4.2.2.2 Liquid Oral Drugs: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.3 Semi-solid Oral Drugs
7.4.2.3.1 Overview
7.4.2.3.2 Semi-solid Oral Drugs: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Topical Drug Delivery
7.5.1 Overview
7.5.2 Topical Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.1 Semi-solid Topical Drug Delivery
7.5.2.1.1 Overview
7.5.2.1.2 Semi-solid Topical Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.2 Liquid Topical Drug Delivery Formulations
7.5.2.2.1 Overview
7.5.2.2.2 Liquid Topical Drug Delivery Formulations: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.3 Solid Topical Drug Delivery Formulations
7.5.2.3.1 Overview
7.5.2.3.2 Solid Topical Drug Delivery Formulations: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.4 Transdermal
7.5.2.4.1 Overview
7.5.2.4.2 Transdermal Patches: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Transmucosal Drug Delivery
7.6.1 Overview
7.6.2 Transmucosal Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.1 Pulmonary and Nasal Drug Delivery
7.6.2.1.1 Overview
7.6.2.1.2 Pulmonary and Nasal Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.2 Buccal and Sublingual Drug Delivery
7.6.2.2.1 Overview
7.6.2.2.2 Buccal and Sublingual Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.3 Rectal Transmucosal Drug Delivery
7.6.2.3.1 Overview
7.6.2.3.2 Rectal Transmucosal Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.4 Vaginal Transmucosal Drug Delivery
7.6.2.4.1 Overview
7.6.2.4.2 Vaginal Transmucosal Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Implantable Drug Delivery
7.7.1 Overview
7.7.2 Implantable Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Ocular Drug Delivery
7.8.1 Overview
7.8.2 Ocular Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.1 Eye Drops and Sprays
7.8.2.1.1 Overview
7.8.2.1.2 Eye Drops and Sprays: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.2 Gels and Ointments
7.8.2.2.1 Overview
7.8.2.2.2 Gels and Ointments: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.3 Ocular Inserts and Punctal Plugs
7.8.2.3.1 Overview
7.8.2.3.2 Ocular Inserts and Punctal Plugs: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.4 Therapeutic Contact Lens
7.8.2.4.1 Overview
7.8.2.4.2 Therapeutic Contact Lens: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
8. ASIA PACIFIC DRUG DELIVERY MARKET – REVENUE AND FORECAST TO 2028 – BY DISTRIBUTION CHANNEL
8.1 Overview
8.2 Asia Pacific Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Retail Pharmacies
8.4.1 Overview
8.4.2 Retail Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Online Pharmacies
8.5.1 Overview
8.5.2 Online Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
9. ASIA PACIFIC DRUG DELIVERY MARKET – REVENUE AND FORECAST TO 2028 – BY END USER
9.1 Overview
9.2 Asia Pacific Drug Delivery Systems Market Revenue Share, by End User (2022and 2028)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Home Care Settings
9.4.1 Overview
9.4.2 Home Care Settings: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Other End User
9.5.1 Overview
9.5.2 Other End User: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
10. ASIA PACIFIC DRUG DELIVERY MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Overview
10.1.1 Asia Pacific Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
10.1.1.1 China: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 China: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 China: Asia Pacific Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.1.3.1 China: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.2 China: Asia Pacific Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.3 China: Asia Pacific Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.4 China: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.5 China: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.4 China: Asia Pacific Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.1.5 China: Asia Pacific Drug Delivery Market, by End User 2020-2028 (US$ Million)
10.1.1.2 Japan: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Japan: Asia Pacific Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.2.3.1 Japan: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.2 Japan: Asia Pacific Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.3 Japan: Asia Pacific Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.4 Japan: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.5 Japan: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.4 Japan: Asia Pacific Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.2.5 Japan: Asia Pacific Drug Delivery Market, by End User 2020-2028 (US$ Million)
10.1.1.3 India: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 India: Asia Pacific Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.3.3.1 India: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.2 India: Asia Pacific Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.3 India: Asia Pacific Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.4 India: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.5 India: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.4 India: Asia Pacific Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.3.5 India: Asia Pacific Drug Delivery Market, by End User 2020-2028 (US$ Million)
10.1.1.4 South Korea: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 South Korea: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 South Korea: Asia Pacific Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.4.3.1 South Korea: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.4.3.2 South Korea: Asia Pacific Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.4.3.3 South Korea: Asia Pacific Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.4.3.4 South Korea: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.4.3.5 South Korea: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.4.4 South Korea: Asia Pacific Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.4.5 South Korea: Asia Pacific Drug Delivery Market, by End User 2020-2028 (US$ Million)
10.1.1.5 Australia: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Australia: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Australia: Asia Pacific Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.5.3.1 Australia: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.5.3.2 Australia: Asia Pacific Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.5.3.3 Australia: Asia Pacific Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.5.3.4 Australia: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.5.3.5 Australia: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.5.4 Australia: Asia Pacific Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.5.5 Australia: Asia Pacific Drug Delivery Market, by End User 2020-2028 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.6.3.1 Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.6.3.2 Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.6.3.3 Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.6.3.4 Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.6.3.5 Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by End User 2020-2028 (US$ Million)
11. ASIA PACIFIC DRUG DELIVERY MARKET – INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in Asia Pacific Drug Delivery Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Becton Dickinson and Co
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Novo Nordisk AS
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Baxter International Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Gerresheimer AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 GlaxoSmithKline Plc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bausch Health Companies Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Boehringer Ingelheim International GmbH
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Novartis AG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.11 Johnson & Johnson
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Pfizer Inc
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. China: Asia Pacific Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 2. China: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 3. China: Asia Pacific Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 4. China: Asia Pacific Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 5. China: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 6. China: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 7. China: Asia Pacific Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 8. China: Asia Pacific Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Japan: Asia Pacific Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 10. Japan: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 11. Japan: Asia Pacific Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 12. Japan: Asia Pacific Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 13. Japan: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 14. Japan: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 15. Japan: Asia Pacific Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 16. Japan: Asia Pacific Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. India: Asia Pacific Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 18. India: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 19. India: Asia Pacific Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 20. India: Asia Pacific Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 21. India: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 22. India: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 23. India: Asia Pacific Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 24. India: Asia Pacific Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. South Korea: Asia Pacific Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 26. South Korea: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 27. South Korea: Asia Pacific Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 28. South Korea: Asia Pacific Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 29. South Korea: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 30. South Korea: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 31. South Korea: Asia Pacific Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 32. South Korea: Asia Pacific Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 33. Australia: Asia Pacific Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 34. Australia: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 35. Australia: Asia Pacific Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 36. Australia: Asia Pacific Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 37. Australia: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 38. Australia: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 39. Australia: Asia Pacific Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 40. Australia: Asia Pacific Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 45. Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 46. Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 47. Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 48. Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 49. Recent Organic Growth Strategies in Asia Pacific Drug Delivery Market
Table 50. Recent Inorganic Growth Strategies in the Asia Pacific Drug Delivery Market
Table 51. Glossary of Terms, Drug delivery market
Table 1. China: Asia Pacific Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 2. China: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 3. China: Asia Pacific Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 4. China: Asia Pacific Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 5. China: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 6. China: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 7. China: Asia Pacific Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 8. China: Asia Pacific Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Japan: Asia Pacific Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 10. Japan: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 11. Japan: Asia Pacific Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 12. Japan: Asia Pacific Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 13. Japan: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 14. Japan: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 15. Japan: Asia Pacific Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 16. Japan: Asia Pacific Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. India: Asia Pacific Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 18. India: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 19. India: Asia Pacific Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 20. India: Asia Pacific Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 21. India: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 22. India: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 23. India: Asia Pacific Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 24. India: Asia Pacific Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. South Korea: Asia Pacific Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 26. South Korea: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 27. South Korea: Asia Pacific Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 28. South Korea: Asia Pacific Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 29. South Korea: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 30. South Korea: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 31. South Korea: Asia Pacific Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 32. South Korea: Asia Pacific Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 33. Australia: Asia Pacific Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 34. Australia: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 35. Australia: Asia Pacific Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 36. Australia: Asia Pacific Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 37. Australia: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 38. Australia: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 39. Australia: Asia Pacific Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 40. Australia: Asia Pacific Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 45. Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 46. Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 47. Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 48. Rest of Asia Pacific: Asia Pacific Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 49. Recent Organic Growth Strategies in Asia Pacific Drug Delivery Market
Table 50. Recent Inorganic Growth Strategies in the Asia Pacific Drug Delivery Market
Table 51. Glossary of Terms, Drug delivery market
LIST OF FIGURES
Figure 1. Asia Pacific Drug Delivery Market Segmentation
Figure 2. Asia Pacific Drug Delivery Market by Country
Figure 3. Asia Pacific Drug Delivery Market Overview
Figure 4. Injectable Drug Delivery to Hold the Largest Share of Route of Administration Segment in Asia Pacific Drug Delivery Market
Figure 5. China Expected to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Asia Pacific Drug Delivery Market Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Drug Delivery Market – Revenue Forecast and Analysis – 2020–2028
Figure 10. Asia Pacific Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
Figure 11. Injectable Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Conventional Injection Devices: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Advanced Devices: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Oral Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Solid Oral Drugs: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Liquid Oral Drugs: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Semi-solid Oral Drugs: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Topical Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Semi-solid Topical Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Liquid Topical Drug Delivery Formulations: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Solid Topical Drug Delivery Formulations: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Transdermal Patches: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Transmucosal Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Pulmonary Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Buccal and Sublingual Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Rectal Transmucosal Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Vaginal Transmucosal Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Implantable Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Ocular Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Eye Drops and Sprays: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Gels and Ointments: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Ocular Inserts and Punctal Plugs: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Therapeutic Contact Lens: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Asia Pacific Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
Figure 35. Hospital Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Retail Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Online Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Asia Pacific Drug Delivery Systems Market Revenue Share, by End User (2022 and 2028)
Figure 39. Hospitals and Clinics: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Home Care Settings: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Other End User: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Asia Pacific Drug Delivery Systems Market, by Key Country – Revenue (2022) (US$ Million)
Figure 43. Asia Pacific Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
Figure 44. China: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Japan: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. India: Asia Pacific Drug Delivery Marke
Figure 1. Asia Pacific Drug Delivery Market Segmentation
Figure 2. Asia Pacific Drug Delivery Market by Country
Figure 3. Asia Pacific Drug Delivery Market Overview
Figure 4. Injectable Drug Delivery to Hold the Largest Share of Route of Administration Segment in Asia Pacific Drug Delivery Market
Figure 5. China Expected to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Asia Pacific Drug Delivery Market Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Drug Delivery Market – Revenue Forecast and Analysis – 2020–2028
Figure 10. Asia Pacific Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
Figure 11. Injectable Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Conventional Injection Devices: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Advanced Devices: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Oral Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Solid Oral Drugs: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Liquid Oral Drugs: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Semi-solid Oral Drugs: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Topical Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Semi-solid Topical Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Liquid Topical Drug Delivery Formulations: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Solid Topical Drug Delivery Formulations: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Transdermal Patches: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Transmucosal Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Pulmonary Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Buccal and Sublingual Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Rectal Transmucosal Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Vaginal Transmucosal Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Implantable Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Ocular Drug Delivery: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Eye Drops and Sprays: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Gels and Ointments: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Ocular Inserts and Punctal Plugs: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Therapeutic Contact Lens: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Asia Pacific Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
Figure 35. Hospital Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Retail Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Online Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Asia Pacific Drug Delivery Systems Market Revenue Share, by End User (2022 and 2028)
Figure 39. Hospitals and Clinics: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Home Care Settings: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Other End User: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Asia Pacific Drug Delivery Systems Market, by Key Country – Revenue (2022) (US$ Million)
Figure 43. Asia Pacific Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
Figure 44. China: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Japan: Asia Pacific Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. India: Asia Pacific Drug Delivery Marke
